Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 13, 2022

Safety of Sulfonylureas vs Antidiabetic Drugs With Low Hypoglycaemic Risk in Adults With Type 2 Diabetes

BMC Endocrine Disorders


Additional Info

Disclosure statements are available on the authors' profiles:

BMC Endocrine Disorders
Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
BMC Endocr Disord 2022 Oct 19;22(1)251, V Volke, U Katus, A Johannson, K Toompere, K Heinla, K Rünkorg, A Uusküla

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading